malondialdehyde has been researched along with Coronary Disease in 121 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (23.97) | 18.7374 |
| 1990's | 40 (33.06) | 18.2507 |
| 2000's | 34 (28.10) | 29.6817 |
| 2010's | 16 (13.22) | 24.3611 |
| 2020's | 2 (1.65) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Fang, X; Guo, D; Hu, Y; Li, X; Zhang, F; Zhou, H | 1 |
| Feng, X; Huang, H; Li, Y; Ren, H; Wang, Y; Yu, S | 1 |
| Pang, Z; Yao, Z; Zhao, W | 1 |
| Asemi, Z; Farrokhian, A; Karami, AA; Raygan, F; Sharifi Esfahani, M; Soltani, A; Tajabadi-Ebrahimi, M | 1 |
| Asemi, Z; Bahmani, F; Ostadmohammadi, V; Raygan, F; Reiter, RJ | 1 |
| Humphries, S; Shahid, SU | 1 |
| Chen, Y; Du, Y; Li, H; Lu, N; Luo, Y; Ouyang, B; Yang, L; Yang, Y | 1 |
| Gorokhova, VG; Koryakina, LB; Kuril'skaya, TE; Kuznetsova, EE; Pivovarov, YI | 1 |
| Arunachalam, C; D'Souza, JM; D'Souza, RP; Faarisa, A; Pai, VR; Shetty, A; Shetty, R; Vijin, VF | 1 |
| Boyle, JJ; Caga-Anan, M; Chang, CL; Haskard, DO; Hughes, AD; Johns, M; Khamis, RY; Kojima, C; Mayet, J; Sattar, N; Sever, P; Welsh, P | 1 |
| de Faire, U; Frostegård, AG; Frostegård, J; Gigante, B; Hellenius, ML; Leander, K; Liu, A; Lundström, SL; Rahman, M; Singh, S; Thiagarajan, D; Vikström, M; Zhang, B; Zubarev, RA | 1 |
| Andreadou, I; Boudoulas, H; Capetanaki, Y; Georgiadou, P; Iliodromitis, EK; Kolokathis, F; Kremastinos, DT; Mavroidis, M; Psarras, S; Varounis, C | 1 |
| Jelic-Ivanovic, Z; Kalimanovska-Ostric, D; Kotur-Stevuljevic, J; Memon, L; Spasic, S; Spasojevic-Kalimanovska, V; Stefanovic, A; Vujovic, A | 1 |
| Chang, HC; Chien, SW; Hu, CY; Lim, PS; Liu, CS; Pai, MA; Wu, MY; Wu, TK | 1 |
| Khabarova, IV; Kratnov, AE | 1 |
| Chiku, M; Fukuda, N; Hirayama, A; Matsumoto, K; Matsumoto, T; Saito, S; Sato, Y; Soma, M; Tahira, K; Takayama, T; Tsunemi, A; Ueno, T; Watanabe, H | 1 |
| Bahçeli, S; Cicek, E; Delibas, N; Yildiz, M | 1 |
| Archbold, GP; Bennati, E; Cambien, F; Murphy, A; Rea, IM; Whitehead, AS; Young, IS | 1 |
| Cao, HY; Li, J; Li, ZQ; Pan, W; Sun, YM; Wang, LF | 1 |
| Likidlilid, A; Patchanans, N; Peerapatdit, T; Sriratanasathavorn, C | 1 |
| Mrudula, SK; Prasad, Y; Prathiba, N; Rajesh, KG; Sanjib, KS; Surekha, RH | 1 |
| Ishii, H; Koyasu, M; Matsubara, T; Murohara, T; Shibata, R; Takemoto, K; Uemura, Y; Watarai, M; Yoshikawa, D | 1 |
| Alonso-Briales, JH; De-Teresa-Galván, E; Fernández-Pastora, J; García-Pinilla, JM; Garrido-Sánchez, L; Hernández-Garcia, JM; Jiménez-Navarro, M; Tinahones, FJ | 1 |
| Liu, ZJ; Shi, B; Wang, ZL | 1 |
| Konovalova, GG; Kukharchuk, VV; Lankin, VZ; Lisina, MO; Nezhdanova, IB; Tikhaze, AK | 1 |
| Jatuporn, S; Prapunwattana, P; Rattanapruks, S; Saengsiri, A; Sangwatanaroj, S; Srimahachota, S; Tangkijvanich, P; Tosukhowong, P; Udayachalerm, W | 1 |
| Jatuporn, S; Kuanoon, W; Panpakdee, O; Rattanapruks, S; Saengsiri, AO; Sangwatanaroj, S; Srimahachota, S; Tangkijvanich, P; Tosukhowong, P; Uthayachalerm, W | 1 |
| Haiyun, L; Honggang, L; Honghai, W; Yijia, L | 1 |
| Amaki, T; Fukino, K; Hayashi, D; Hibi, N; Imai, Y; Kitano, S; Morita, H; Nagai, R; Nakamura, F; Nojiri, T; Suzuki, T; Yamazaki, T | 1 |
| Li, GX; Li, P | 1 |
| Mao, JM; Wang, G; Wang, X; Zhang, FC | 1 |
| Huang, R; Ma, Y; Su, X; Wang, X; Wang, Y | 1 |
| Aaronson, PI; Borrás, C; Khan, IY; Knock, GA; Mahn, K; Mann, GE; Poston, L; Sharpe, RM; Sugden, D; Taylor, P; Viña, J; Ward, JP | 1 |
| Akay, T; Arslan, A; Aslamaci, S; Gultekin, B; Ozkan, S; Sezgin, A; Tasdelen, A; Uguz, E | 1 |
| Anazawa, T; Furukawa, K; Kanmatsuse, K; Kawamata, H; Kushiro, T; Nagao, K; Sato, Y; Tachibana, E; Tani, S; Watanabe, I | 1 |
| Dwivedi, S; Kumar, N; Lal, MK; Prabhu, KM; Sharma, SB; Singh, G | 1 |
| Han, H; Lin, H; Liu, Y; Wang, H; Wang, Z; Xu, C; Yang, B | 1 |
| Andreadou, I; Ikonomidis, I; Karatzi, KN; Karatzis, EN; Lekakis, JP; Papaioannou, TG; Papamichael, CM; Protogerou, AD; Vamvakou, GD; Voidonikola, PT | 1 |
| Chavan, V; Karnik, ND; Patil, N | 1 |
| Mahajan, M; Sharma, R; Singh, B | 1 |
| Arós, F; Cabezas, C; Corella, D; Covas, MI; de la Torre, R; Estruch, R; Fiol, M; Fitó, M; Francés, F; García-Arellano, A; Guxens, M; López-Sabater, MDC; Marrugat, J; Ros, E; Ruiz-Gutierrez, V; Sáez, G; Salas-Salvadó, J; Solá, R | 1 |
| Baker, SG; Birnbaum, M; Bradlow, BA; Chetty, N; Seftel, HC | 1 |
| Alexander, RW; Handin, RI; Schafer, AI | 1 |
| Bernardoni, R; Ferretti, ME; Meduri, P; Strozzi, C; Vallini, R | 1 |
| Cohen, MV; Mueller, HS; Rao, PS | 1 |
| Motomiya, T; Sano, T; Yamazaki, H | 1 |
| Matkovics, B; Röth, E; Szabó, L; Tigyi, A; Török, B; Zsoldos, T | 1 |
| Bast, A; Julicher, RH; Koomen, JM; Noordhoek, J; Sterrenberg, L; Tijburg, LB | 1 |
| Bazanov, EA; Gasilin, VS; Kurdanov, KhA; Zykova, VP | 1 |
| Aznar, J; Fernandez, MA; Santos, MT; Valles, J | 1 |
| Dubur, GIa; Frol'kis, RA; Gomon, IV; Tsiomik, VA; Voronkov, GS | 1 |
| Conti, CR; Mehta, J; Mehta, P | 1 |
| Bertrand, M; Boullier, A; Duriez, P; Fruchart, JC; Hamon, M; Mackereel, R; Martin-Nizart, F; Walters-Laporte, E | 1 |
| Das, UN | 1 |
| Birkenhäger, JC; Ghanem, H; Jansen, H; Kuypers, JH | 1 |
| Armstrong, VW; Diedrich, F; Kreuzer, H; Kuhn, W; Oellerich, M; Rath, W; Renner, A; Wieland, E | 1 |
| Boucher, F; de Leiris, J; Pucheu, S; Sulpice, T | 1 |
| Yang, LX; Zhu, SJ | 1 |
| Gurevich, VS; Klimov, AN; Kuzmin, AA; Nikiforova, AA; Plavinsky, SL; Shatilina, LV; Teryukova, NP | 1 |
| Gao, SB; Han, DY; He, SF; Jia, GL; Jin, YF; Qian, XX; Wen, Y | 1 |
| Buczyński, A; Kedziora, J; Kedziora-Kornatowska, K; Tkaczewski, W; Wachowicz, B | 1 |
| Arnaud, J; Boissonnat, P; de Lorgeril, M; Dureau, G; Favier, A; Guidollet, J; Renaud, S; Richard, MJ | 1 |
| Karpati, E; Lantos, J; Matos, G; Paróczai, M; Roth, E; Temes, G | 1 |
| Akita, S; Fujinami, T; Hibino, T; Ohte, N; Sakuma, N; Sasai, K; Sato, T; Tamai, N; Yoshimata, T | 1 |
| Ihnken, K; Mülsch, A; Neidhart, G; Sarai, K; Schlensak, C; Sewell, A; Unkelbach, U; Winkler, A | 1 |
| Fadiloglu, M; Koseoglu, MH | 1 |
| Collen, D; Holvoet, P; Janssens, S; Van de Werf, F; Vanhaecke, J | 1 |
| Birincioğlu, L; Işcan, Z; Katircioğlu, SF; Saritaş, Z; Ulus, AT; Yamak, B | 1 |
| Luo, HC; Luo, ZQ; Qiu, RX | 1 |
| Jia, Z; Sun, M; Wang, Q; Zhou, H | 1 |
| Niaz, MA; Rastogi, SS; Shukla, PK; Singh, RB; Thakur, AS | 1 |
| Deng, JH; Jin, MH; Qin, J | 1 |
| Collen, D; Holvoet, P; Van de Werf, F | 1 |
| Laperrière, L; Latour, JG; Libersan, D; Merhi, Y; Quan, E; Uzan, A | 1 |
| Chen, H; Li, D; Mehta, JL; Mehta, P; Phillips, MI; Shi, M; Zhang, YC | 1 |
| Dirican, M; Sarandöl, E; Serdar, A; Serdar, Z; Tokullugil, A; Yeşilbursa, D | 1 |
| Kulakova, SN; Levachev, MM; Pogozheva, AV; Pokrovskaia, GR; Trushina, EN | 1 |
| Cummings, PM; Genest, JJ; Giddens, K; Nassar, BA; Title, LM | 1 |
| Baseer, A; Khan, MA | 1 |
| Kolycheva, SV; Lankin, VZ; Tikhaze, AK; Zharova, EA | 1 |
| Aggarwal, HK; Budhiraja, N; Nand, N; Sharma, M; Singh, GP | 1 |
| Jang, Y; Kim, OY; Lee, JH; Lee, SY; Park, HY | 1 |
| Bassi, A; Bozzini, C; Corrocher, R; Faccini, G; Girelli, D; Olivieri, O; Pignatti, PF; Stranieri, C; Tinazzi, E; Trabetti, E | 1 |
| Bujo, H; Inoue, M; Kanno, T; Kotani, K; Mikami, K; Saito, Y; Takahashi, K; Tanaga, K | 1 |
| Cho, SY; Hong, BK; Kim, DS; Kim, HS; Kim, JH; Kwon, HM; Kwon, KH; Lee, JY; Park, BE; Park, HY; Ryu, SK; Yoon, YW | 1 |
| Bailer, H; Griebenow, S; Scheidleder, B; Winkler, R | 1 |
| Grodzińska, L; Gryglewski, RJ; Marcinkiewicz, E; Musiał, J; Serwońska, M; Szczeklik, A | 1 |
| Dong, CR; Ling, H; Ruan, HD | 1 |
| Feher, J; Hajdu, E; Toncsev, H; Vereckei, A | 1 |
| Belch, JJ; Bridges, AB; McNeill, GP; Pringle, TH; Scott, NA | 1 |
| Das, DK; Engelman, RM; Iyengar, J; Kimura, Y | 1 |
| Cuddy, TE; Liu, KZ; Pierce, GN | 1 |
| Benigno, M; Cargnoni, A; Ceconi, C; Curello, S; Ferrari, R; Pasini, E; Visioli, O | 1 |
| Barcew-Wiszniewska, B; Krasowska, B; Rózewicka, L; Samochowiec, L; Wójcicki, J | 1 |
| Azizova, OA; Panasenko, OM; Vladimirov, YA; Vol'nova, TV | 1 |
| Gu, T; Wang, A | 1 |
| Cargnoni, A; Ceconi, C; Condorelli, E; Curello, S; Ferrari, R; Pasini, E | 1 |
| Ibragimova, EI; Solov'ev, OV; Tuev, AV | 1 |
| Asetskaia, IL; Azizova, OA; Egorov, DIu; Kozlov, Av; Lopukhin, IuM; Markin, SS; Nalivaĭko, ES; Sergienko, VI; Vladimirov, IuA | 1 |
| Belch, JJ; Chopra, M; Cobbe, SM; Oldroyd, KG; Rankin, AC | 1 |
| Belch, JJ; Bridges, A; Chopra, M; McLay, J; McMurray, J | 1 |
| Kots, IaI; Lankin, VZ; Saifutdinov, RI; Tikhaze, AK | 1 |
| Mao, N | 1 |
| Chen, JX; Li, X; Sun, JJ | 1 |
| Carlomagno, L; Gambassi, F; Giannella, E; Mannaioni, PF; Masini, E; Palmerani, B; Pistelli, A | 1 |
| Buchalik, J; Buczyński, A; Dziedziczak-Buczyńska, M; Kedziora, H; Kedziora, J; Tkaczewski, W | 1 |
| Bando, K; Senoo, Y | 1 |
| Heine, H; Misselwitz, F; Norden, C | 1 |
| Azizova, OA; Belousov, IuB; Borin, ML; Gutkin, AB; Razumov, VB | 1 |
| Cherkesov, VV; Kopytina, RA; Kudinova, TV; Ursakiĭ, TN | 1 |
| Bergmann, SR; Koller, PT | 1 |
| Gordon-Majszak, W; Herbaczyńska-Cedro, K | 1 |
| Artigou, JY; Bedu, O; Emerit, J; Fechner, J; Goy, J; Grosgogeat, Y; Loeper, J | 1 |
| Artigou, JL; Emerit, J; Fechner, J; Goy, J; Grosgogeat, Y | 1 |
| Guarnieri, C; Hartog, JM; Koster, JF; Lamers, JM; Vaona, I; Verdouw, PD | 1 |
| Bazzan, M; Bosia, A; Bussolino, F; Ghigo, D; Libero, L; Orzan, F; Pannocchia, A; Tamponi, G; Treves, S | 1 |
| Haberland, A; Küttner, I; Schimke, I; Will-Shahab, L | 1 |
| Chen, X; Deng, HW; Li, DY; Li, YJ; Shen, N; Yang, BC | 1 |
| Breyer, RH; Das, DK; Engelman, RM; Lemeshow, S; Otani, H; Rousou, JA | 1 |
| Köhler, H; Peters, HJ; Reuter, W; Voigt, H; Vorberg, B | 1 |
| Bodnar, PN; Kurik, MV; Pristupiuk, AM | 1 |
21 trial(s) available for malondialdehyde and Coronary Disease
| Article | Year |
|---|---|
Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
Topics: Blood Pressure; Cardiotonic Agents; Coronary Disease; Creatine Kinase, MB Form; Diastole; Elective Surgical Procedures; Female; Heart Rate; Humans; Male; Malondialdehyde; Middle Aged; Nicorandil; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Peroxidase; Stroke Volume; Systole; Troponin I | 2017 |
The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Coronary Disease; Diabetes Mellitus; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Malondialdehyde; Middle Aged; Overweight; Oxidative Stress; Synbiotics | 2019 |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glutathione; Humans; Insulin; Male; Malondialdehyde; Melatonin; Middle Aged; Nitric Oxide; Oxidative Stress | 2019 |
High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Aged; Antihypertensive Agents; Area Under Curve; C-Reactive Protein; Case-Control Studies; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Hypertension; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Odds Ratio; Peptide Fragments; Risk Factors; ROC Curve | 2016 |
Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease.
Topics: Aged; Analysis of Variance; Atorvastatin; Biomarkers; Chi-Square Distribution; Coronary Disease; Diet, Fat-Restricted; Female; Glutathione; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Function Tests; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Pyrroles; Simvastatin; Superoxide Dismutase; Treatment Outcome | 2010 |
Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
Topics: Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Atorvastatin; Azetidines; Cholesterol; Cholesterol, LDL; Coronary Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ezetimibe; Female; Glucose Intolerance; Heptanoic Acids; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Oxidation-Reduction; Prospective Studies; Pyrroles | 2012 |
[Effects of di'ao xinxuekang soft capsule on lipid peroxidation and the endothelial function in patients with coronary heart disease].
Topics: Aged; Coronary Disease; Drugs, Chinese Herbal; Endothelins; Endothelium, Vascular; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Phytotherapy; Superoxide Dismutase | 2012 |
Short-term effects of an intensive lifestyle modification program on lipid peroxidation and antioxidant systems in patients with coronary artery disease.
Topics: Aged; Antioxidants; Ascorbic Acid; Coronary Disease; Diet, Fat-Restricted; Dietary Fiber; Exercise Therapy; Female; Glutathione; Humans; Imagery, Psychotherapy; Life Style; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Relaxation Therapy; Smoking Cessation; Stress, Psychological; Vitamin E; Yoga | 2003 |
Effects of shenmai injection on blood SOD activity and MDA level in senile patients with coronary heart disease.
Topics: Aged; Angina Pectoris; Coronary Disease; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Male; Malondialdehyde; Middle Aged; Phytotherapy; Plant Extracts; Superoxide Dismutase | 2005 |
Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection.
Topics: Adult; Aged; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Disease; Creatine Kinase; Female; Glucose; Heart Arrest, Induced; Humans; Male; Malondialdehyde; Mannitol; Middle Aged; Myocardial Ischemia; Potassium Chloride; Procaine; Prospective Studies; Troponin I | 2005 |
Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound.
Topics: Anticholesteremic Agents; Cholesterol; Coronary Disease; Diabetes Mellitus; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pravastatin; Risk Factors; Smoking; Ultrasonography | 2005 |
Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol; Coronary Disease; Diet, Fat-Restricted; Diet, Mediterranean; Energy Intake; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Triglycerides | 2007 |
Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
Topics: Aged; Antigen-Antibody Complex; Autoantibodies; Biomarkers; Cholesterol; Coronary Angiography; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Smoking | 1995 |
Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B.
Topics: Autoantibodies; Coronary Disease; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pravastatin | 1995 |
Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult.
Topics: Adult; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Creatine Kinase; Female; Humans; L-Lactate Dehydrogenase; Leukocyte Elastase; Male; Malondialdehyde; Middle Aged; Myocardial Reperfusion Injury; Neutrophils; Nitric Oxide; Oxidative Stress; Oxygen Inhalation Therapy; Postoperative Period; Reactive Oxygen Species; Respiratory Burst; Respiratory Function Tests; Retrospective Studies; Ventricular Function, Left | 1998 |
[Effect of xinmaitong capsule on damage of lipid peroxidation in coronary heart disease patients with myocardial ischemia].
Topics: Capsules; Coronary Disease; Drugs, Chinese Herbal; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Panax; Phytotherapy; Plants, Medicinal; Superoxide Dismutase | 1997 |
Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease.
Topics: Administration, Oral; Antioxidants; Blood Glucose; Blood Pressure; Coenzymes; Coronary Disease; Cytoprotection; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Surveys and Questionnaires; Treatment Outcome; Triglycerides; Ubiquinone | 1999 |
[Clinical-metabolic evaluation of the effectiveness of the olive oil use in patients with cardiovascular diseases].
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Disease; Dietary Fats, Unsaturated; Erythrocyte Membrane; Erythrocytes; Female; Humans; Hyperlipoproteinemias; Hypertension; Lipid Peroxidation; Lymphocyte Activation; Male; Malondialdehyde; Membrane Lipids; Middle Aged; Olive Oil; Plant Oils; Rosette Formation; Time Factors | 2000 |
Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
Topics: Aged; Antioxidants; Ascorbic Acid; Blood Circulation; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Lipids; Male; Malondialdehyde; Middle Aged; Nitroglycerin; Vasodilation; Vasodilator Agents; Vitamin B 12; Vitamin E | 2000 |
Trimetazidine as indirect antioxidant.
Topics: Angina Pectoris; Antioxidants; Coronary Disease; Erythrocytes; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Trimetazidine; Vasodilator Agents | 2000 |
Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial.
Topics: Area Under Curve; Blood Glucose; Carotenoids; Cholesterol, HDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Dinoprost; Edible Grain; F2-Isoprostanes; Fabaceae; Glucose Tolerance Test; Homocysteine; Humans; Insulin; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Powders; Risk Factors | 2001 |
100 other study(ies) available for malondialdehyde and Coronary Disease
| Article | Year |
|---|---|
Interplay of TNF-α, soluble TNF receptors and oxidative stress in coronary chronic total occlusion of the oldest patients with coronary heart disease.
Topics: Aged, 80 and over; Aldosterone; Angiotensin II; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Angiography; Coronary Disease; Coronary Occlusion; Echocardiography; Female; Humans; Male; Malondialdehyde; Oxidative Stress; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |
Low-Dose Ozone Therapy Improves Sleep Quality in Patients with Insomnia and Coronary Heart Disease by Elevating Serum BDNF and GABA.
Topics: Brain-Derived Neurotrophic Factor; Catalase; Coronary Disease; Depression; gamma-Aminobutyric Acid; Humans; Malondialdehyde; Ozone; Saliva; Sleep Initiation and Maintenance Disorders | 2021 |
The SNP rs10911021 is associated with oxidative stress in coronary heart disease patients from Pakistan.
Topics: Aged; Alleles; Biomarkers; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Female; Gene Expression; Gene Frequency; Genotype; Glutamate-Ammonia Ligase; Glutathione; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pakistan; Polymorphism, Single Nucleotide | 2018 |
Omega-6 fatty acids down-regulate matrix metalloproteinase expression in a coronary heart disease-induced rat model.
Topics: Animals; Antioxidants; Catalase; Coronary Disease; Disease Models, Animal; Down-Regulation; Fatty Acids, Omega-6; Gene Expression Regulation; Glutathione Peroxidase; Male; Malondialdehyde; Matrix Metalloproteinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase | 2018 |
Role of Endogenous Factors in Response of Erythrocyte Membrane in Patients with Cardiovascular Diseases under Conditions of Ischemic Exposure.
Topics: Adsorption; Adult; Angina, Stable; Arm; Blood Viscosity; Brachial Artery; Constriction; Coronary Disease; Erythrocyte Membrane; Fibrinogen; Hemoglobins; Humans; Ischemia; Lipids; Male; Malondialdehyde; Middle Aged; Nucleotides; Plasminogen; Platelet Adhesiveness; von Willebrand Factor | 2015 |
High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Predictive Value of Tests; ROC Curve; Serum Albumin; Vascular Diseases | 2016 |
Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.
Topics: Aged; Angina Pectoris; Autoantibodies; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Hospitalization; Humans; Immunoglobulin M; Incidence; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Prospective Studies; Serum Albumin; Stroke; Sweden | 2016 |
Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease.
Topics: Adult; Aged; Coronary Disease; Diabetes Mellitus; Female; Humans; Linear Models; Male; Malondialdehyde; Middle Aged; Osteopontin; Oxidative Stress; Risk Factors | 2008 |
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Topics: Aryldialkylphosphatase; Coronary Disease; Female; Humans; Inflammation; Male; Malondialdehyde; Middle Aged; Organophosphorus Compounds; Oxidative Stress; Paraoxon; Phenotype | 2008 |
Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Case-Control Studies; CD40 Ligand; Coronary Disease; Cross-Sectional Studies; Female; Humans; Inflammation Mediators; Kidney Failure, Chronic; Lipids; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Protein Carbonylation; Renal Dialysis; Tyrosine; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2008 |
[Neutrophilic intracellular metabolic changes and fatal outcome in coronary heart disease].
Topics: Age Factors; Aged; Antigen-Antibody Complex; C-Reactive Protein; Coronary Disease; Female; Glutathione Reductase; Humans; Lactic Acid; Leukocyte Count; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Neutrophils; Peroxidase | 2009 |
Influence of genetic polymorphisms in oxidative stress related genes and smoking on plasma MDA-LDL, soluble CD40 ligand, E-selectin and soluble ICAM1 levels in patients with coronary artery disease.
Topics: Aged; CD40 Ligand; Coronary Disease; E-Selectin; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Malondialdehyde; Middle Aged; NADPH Oxidases; Oxidative Stress; Polymorphism, Genetic; Smoking; Solubility | 2009 |
The effects of 201Tl myocardial perfusion scintigraphy studies on oxidative damage in patients.
Topics: Adult; Aged; Analysis of Variance; Catalase; Coronary Disease; Erythrocytes; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Radionuclide Imaging; Radiopharmaceuticals; Superoxide Dismutase; Thallium Radioisotopes | 2009 |
BELFAST centenarians: a case of optimised cardiovascular risk?
Topics: Aged, 80 and over; Antioxidants; Apolipoproteins E; Blood Glucose; Blood Pressure; Body Mass Index; Cause of Death; Cholesterol, LDL; Coronary Disease; Female; Geriatric Assessment; Humans; Lipoproteins; Longevity; Longitudinal Studies; Male; Malondialdehyde; Northern Ireland; Peptidyl-Dipeptidase A; Phenotype; Risk Assessment; Risk Factors | 2010 |
Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Case-Control Studies; Catalase; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Erythrocytes; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase | 2010 |
Oxidative and nitrosative stress in association with DNA damage in coronary heart disease.
Topics: Adult; Aged; Angiography; Antioxidants; Case-Control Studies; Comet Assay; Coronary Disease; DNA; DNA Damage; Female; Humans; Lipids; Male; Malondialdehyde; Middle Aged; Nitrogen; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species | 2011 |
Reduced levels of anti-MDA LDL antibodies in patients with carbohydrate metabolism disorders.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antibody Specificity; Autoantigens; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypercholesterolemia; Hypertension; Immunoglobulin G; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Prognosis; Renal Insufficiency | 2011 |
Complex of vitamins and antioxidants protects low-density lipoproteins in blood plasma from free radical oxidation and activates antioxidants enzymes in erythrocytes from patients with coronary heart disease.
Topics: Adult; Aged; Antioxidants; Catalase; Coronary Disease; Erythrocytes; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxides; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Selenium; Superoxide Dismutase; Vitamins | 2003 |
The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients.
Topics: Antioxidants; Biomarkers; Blood Glucose; Blood Proteins; Cholesterol; Coronary Angiography; Coronary Disease; Dehydroascorbic Acid; Disease Susceptibility; Erythrocytes; Female; Glutathione; Glutathione Peroxidase; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Risk Factors; Sulfhydryl Compounds; Thailand; Triglycerides; Vitamin E | 2003 |
Protective effect of total flavones from Elsholtzia blanda (TFEB) on myocardial ischemia induced by coronary occlusion in canines.
Topics: Animals; Coronary Disease; Creatine Kinase; Dogs; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Flavones; Hemodynamics; Hemorheology; Lamiaceae; Male; Malondialdehyde; Myocardial Ischemia; Phytotherapy | 2004 |
Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease.
Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol, LDL; Coronary Disease; Female; Humans; Male; Malondialdehyde; Middle Aged; ROC Curve | 2004 |
[Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
Topics: Antioxidants; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Female; Glutathione; Humans; Lipid Peroxides; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction | 2004 |
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Chemokine CCL2; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase | 2004 |
Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo.
Topics: Animal Feed; Animals; Antioxidants; Aorta; Blood Pressure; Coronary Disease; Endothelium, Vascular; Female; Gene Expression Regulation, Enzymologic; Genistein; Glycine max; Isoflavones; Liver; Male; Malondialdehyde; Models, Biological; Models, Chemical; Nitric Oxide Synthase Type III; Oxidative Stress; Phytoestrogens; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |
Coronary risk variables in young asymptomatic smokers.
Topics: Adult; Age Factors; Apolipoproteins B; Blood Pressure; Coronary Disease; Electrocardiography; Free Radicals; Humans; India; Lipids; Male; Malondialdehyde; Risk Factors; Smoking; Superoxide Dismutase | 2005 |
Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Calcium; Cells, Cultured; Choline; Coronary Disease; Cytoprotection; Male; Malondialdehyde; MAP Kinase Signaling System; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Receptor, Muscarinic M3; Superoxide Dismutase | 2005 |
Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation.
Topics: Acute Disease; Brachial Artery; Coronary Disease; Endothelium, Vascular; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Revascularization; Oxidative Stress; Prognosis; Stroke Volume; Syndrome; Ultrasonics; Vasodilation | 2006 |
Study of leukocytic hydrolytic enzymes in patients with acute stage of coronary heart disease.
Topics: Acid Phosphatase; Acute Disease; Adult; Angina, Unstable; Cathepsin G; Cathepsins; Coronary Disease; Female; Humans; Leukocytes; Male; Malondialdehyde; Middle Aged; Muramidase; Myocardial Infarction; Serine Endopeptidases | 2007 |
PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Topics: Adult; Aged; Apolipoprotein B-100; Aryldialkylphosphatase; Cholesterol, HDL; Coronary Disease; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction | 2007 |
Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.
Topics: Adolescent; Adult; Aged; beta-Thromboglobulin; Child; Cholesterol; Coronary Disease; Female; Humans; Hyperlipoproteinemia Type II; Male; Malondialdehyde; Middle Aged; Phenols; Platelet Aggregation; Probucol; South Africa | 1982 |
Inhibition of platelet function by organic nitrate vasodilators.
Topics: Adenylyl Cyclases; Arachidonic Acids; Coronary Disease; Cyclic AMP; Humans; Malondialdehyde; Nitroglycerin; Oxygen Consumption; Platelet Aggregation | 1980 |
Some biochemical platelet patterns in stable coronary patients.
Topics: Aged; Angina Pectoris; Blood Platelets; Coronary Disease; Cyclic AMP; Female; Humans; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Thrombin | 1983 |
Production of free radicals and lipid peroxides in early experimental myocardial ischemia.
Topics: Animals; Ascorbic Acid; Catecholamines; Coronary Disease; Dogs; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione Peroxidase; Kinetics; Lipid Peroxides; Malondialdehyde; Oxidation-Reduction | 1983 |
Influence of lipids metabolism on platelet activation in vivo.
Topics: Adult; Aged; Antigens; Blood Platelets; Coronary Disease; Factor VIII; Female; Humans; Hyperlipidemias; In Vitro Techniques; Isometric Contraction; Lipid Metabolism; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Ultrafiltration; von Willebrand Factor | 1983 |
Membrane perturbations in myocardium: oxygen radicals mediate injuries in experiments.
Topics: Animals; Cell Membrane; Coronary Disease; Dogs; Free Radicals; Hypoxia; Lipid Metabolism; Malondialdehyde; Myocardium; Oxygen Consumption; Rats; Rats, Inbred Strains | 1984 |
Decreased defence against free radicals in rat heart during normal reperfusion after hypoxic, ischemic and calcium-free perfusion.
Topics: Animals; Benzene Derivatives; Calcium; Coronary Disease; Free Radicals; Glutathione; Heart; Hypoxia; In Vitro Techniques; Kinetics; Lipid Peroxides; Male; Malondialdehyde; Myocardium; Perfusion; Rats; Superoxide Dismutase | 1984 |
[Malondialdehyde content of plasma lipoproteins and thrombocytes in patients with ischemic heart disease].
Topics: Adult; Blood Platelets; Coronary Disease; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Malonates; Malondialdehyde; Middle Aged; Neurocirculatory Asthenia | 1984 |
Elevated lipid peroxide levels in platelets of chronic ischemic heart disease patients.
Topics: Anticoagulants; Aspirin; Blood Platelets; Chronic Disease; Citrates; Citric Acid; Coronary Disease; Edetic Acid; Humans; Lipid Peroxides; Male; Malondialdehyde; Physical Stimulation | 1982 |
[Creatine phosphokinase activity in myocardial sarcoplasmic reticulum membranes in experimental coronary insufficiency].
Topics: Animals; Antioxidants; Coronary Disease; Creatine Kinase; Intracellular Membranes; Malondialdehyde; Myocardium; Organic Chemicals; Phospholipids; Rabbits; Sarcoplasmic Reticulum | 1983 |
Platelet function studies in coronary heart disease. IX. Increased platelet prostaglandin generation and abnormal platelet sensitivity to prostacyclin and endoperoxide analog in angina pectoris.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Angina Pectoris; Blood Platelets; Coronary Disease; Epoprostenol; Humans; Malondialdehyde; Middle Aged; Platelet Function Tests; Prostaglandin Endoperoxides, Synthetic; Prostaglandins | 1980 |
Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease.
Topics: Adult; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Humans; Hypertension; India; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Phospholipids | 1995 |
Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Coronary Disease; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pre-Eclampsia; Pregnancy | 1994 |
Contribution of leukocyte infiltration to lipoperoxidation occurring in the non-ischemic region of the rat heart submitted to permanent left coronary artery occlusion.
Topics: Animals; Constriction; Coronary Disease; Fluorescent Antibody Technique; Indomethacin; Inflammation; Leukocytes; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Peroxidase; Rats; Rats, Wistar; Time Factors | 1994 |
[The significance of endothelial injury in the pathogenesis of coronary heart disease].
Topics: Aged; Cell Count; Coronary Disease; Endothelium, Vascular; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged | 1993 |
Antioxidative activity of high density lipoproteins in vivo.
Topics: Animals; Antioxidants; Coronary Disease; Humans; Hypercholesterolemia; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, HDL3; Male; Malondialdehyde; Middle Aged; Rabbits | 1993 |
Correlation of serum lipids, lipoproteins, lipid peroxide products and metals with coronary heart disease.
Topics: Cholesterol; Coronary Disease; Female; Humans; Lipoproteins; Male; Malondialdehyde; Middle Aged; Trace Elements; Triglycerides | 1993 |
Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Antioxidants; Blood Platelets; Catalase; Coronary Disease; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Superoxide Dismutase; Thrombin | 1993 |
Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis.
Topics: Adult; Aged; Antioxidants; Coronary Artery Disease; Coronary Disease; Heart Transplantation; Humans; Lipid Peroxides; Malondialdehyde; Middle Aged; Postoperative Complications; Trace Elements | 1993 |
Effects of bisaramil on coronary-occlusion-reperfusion injury and free-radical-induced reactions.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Catalase; Chlorobenzenes; Coronary Disease; Dogs; Erythrocytes; Female; Free Radicals; Glutathione; Hemodynamics; Male; Malondialdehyde; Myocardial Reperfusion Injury; Neutrophils; Superoxide Dismutase | 1996 |
Levels of thiobarbituric acid-reactive substance in plasma from coronary artery disease patients.
Topics: Aged; Cholesterol; Cholesterol, HDL; Coronary Disease; Humans; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Thiobarbituric Acid Reactive Substances; Triglycerides | 1997 |
Relationship between serum fatty acids and malondialdehyde (MDA) levels in coronary artery disease diagnosed (CAD) patients.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fatty Acids; Humans; Malondialdehyde; Reference Values; Regression Analysis; Triglycerides | 1998 |
Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.
Topics: Aged; Angina Pectoris; Arteries; C-Reactive Protein; Coronary Disease; Coronary Vessels; Female; Fibrin Fibrinogen Degradation Products; Heart Transplantation; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Regression Analysis; Troponin I | 1998 |
Preservation of myocardial metabolism in acute coronary artery occlusions with retrograde coronary sinus perfusion and iloprost.
Topics: Animals; Coronary Disease; Creatine Kinase; Dogs; Heart; Hemodynamics; Iloprost; Intercellular Adhesion Molecule-1; Malondialdehyde; Myocardium; Perfusion; Selectins; Sulfhydryl Compounds; Tumor Necrosis Factor-alpha | 1998 |
[Effects of smoking on oxygen free radicals and fibrinolytic system].
Topics: Adult; Coronary Disease; Humans; Male; Malondialdehyde; Middle Aged; Plasminogen Activator Inhibitor 1; Smoking; Superoxide Dismutase; Tissue Plasminogen Activator | 1997 |
[Clinical study of eliminating dampness and removing blood stasis in treating coronary heart disease--the summary about serial study of blood stasis due to dampness].
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Diagnosis, Differential; Drugs, Chinese Herbal; Epoprostenol; Female; Hemorheology; Humans; Male; Malondialdehyde; Medicine, Chinese Traditional; Middle Aged; Superoxide Dismutase; Thromboxane A2 | 1997 |
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
Topics: Acute Disease; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Female; Humans; Logistic Models; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; ROC Curve; Sensitivity and Specificity; Troponin I | 1999 |
Intravenous aspirin at reperfusion does not reduce infarct size in the dog with a residual critical stenosis.
Topics: 6-Ketoprostaglandin F1 alpha; Anesthesia; Animals; Aspirin; Blood Cell Count; Cell Movement; Coronary Disease; Dogs; Female; Infarction; Infusions, Intravenous; Male; Malondialdehyde; Neutrophils; Platelet Aggregation; Reperfusion Injury | 1999 |
Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
Topics: Animals; Coronary Circulation; Coronary Disease; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; RNA, Messenger; Stroke Volume; Ventricular Dysfunction, Left | 2000 |
Relation between lipoprotein (a) and in vitro oxidation of apolipoprotein B-containing lipoproteins.
Topics: Adult; Aged; Apolipoproteins B; Carotenoids; Coronary Angiography; Coronary Disease; Female; Humans; Lipid Peroxidation; Lipoprotein(a); Male; Malondialdehyde; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Vitamin E | 2000 |
Increased malondialdehyde levels in coronary heart disease.
Topics: Adult; Coronary Disease; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged | 2000 |
Lipid peroxidation and vitamin E in ischemic heart disease.
Topics: Coronary Disease; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Vitamin E | 1997 |
Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Ferritins; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histocompatibility Antigens Class I; HLA Antigens; Humans; Inflammation; Iron; Iron Deficiencies; Lipid Peroxidation; Male; Malondialdehyde; Membrane Proteins; Middle Aged; Mutation; Risk Factors | 2002 |
Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles.
Topics: Aged; Biomarkers; Carotid Artery Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Triglycerides | 2002 |
Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with non-diabetic unstable angina: a potential role in immunologic reaction of plaque instability.
Topics: Aged; Angina, Unstable; Antibody Formation; Autoantibodies; Coronary Disease; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged | 2002 |
[Effects of high iodine doses in parenteral roentgen contrast media administration on parameters of the pro-/antioxidant balance].
Topics: Adult; Aged; Antioxidants; Contrast Media; Coronary Angiography; Coronary Disease; Female; Glutathione Peroxidase; Health Resorts; Homeostasis; Humans; Iopamidol; Male; Malondialdehyde; Middle Aged; Peroxides; Reference Values; Superoxide Dismutase; Vitamin E | 2002 |
Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
Topics: Adult; Arachidonic Acids; Aspirin; Blood Platelets; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Malonates; Malondialdehyde; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1979 |
The effects of normovolemic hemodilution with dextran-40 on acute myocardial ischemia/reperfusion injury in rabbits.
Topics: Animals; Coronary Disease; Dextrans; Female; Hemodilution; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Rabbits; Superoxide Dismutase | 1992 |
Relationship between the extent of coronary artery disease and indicators of free radical activity.
Topics: Arteriosclerosis; Coronary Disease; Free Radicals; Glutathione; Humans; Malondialdehyde; Sulfhydryl Compounds; Superoxide Dismutase | 1992 |
Relationship between the extent of coronary artery disease and indicators of free radical activity.
Topics: Aged; Angina Pectoris; Cholesterol; Coronary Disease; Female; Free Radicals; Glutathione; Humans; Male; Malondialdehyde; Middle Aged; Sulfhydryl Compounds; Superoxide Dismutase | 1992 |
Prevention of myocardial reperfusion injury in experimental coronary revascularization following ischemic arrest by a novel antiinflammatory drug, ONO-3144.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Coronary Disease; Creatine Kinase; Female; Free Radicals; Heart Arrest, Induced; Heart Function Tests; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardial Revascularization; Oxygen Consumption; Propiophenones; Prostaglandins F; Superoxides; Swine; Thromboxane B2 | 1990 |
Oxidative status of lipoproteins in coronary disease patients.
Topics: Cholestenones; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Chromatography, High Pressure Liquid; Coronary Disease; Female; Humans; Hydroxycholesterols; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged | 1992 |
[Is lipid peroxidation responsible for the damage caused by postischemic reperfusion?].
Topics: Animals; Chromatography, High Pressure Liquid; Colorimetry; Coronary Disease; Creatine Kinase; Indicators and Reagents; Lipid Peroxidation; Malondialdehyde; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Rabbits; Thiobarbiturates; Time Factors | 1991 |
Protective effect of selenium and vitamin E against changes induced in heart vessels of rabbits fed chronically on a high-fat diet.
Topics: Animals; Arteriosclerosis; Coronary Disease; Diet, Atherogenic; Drug Synergism; Endothelium, Vascular; Lipids; Male; Malondialdehyde; Rabbits; Selenium; Vitamin E | 1991 |
Free radical modification of lipoproteins and cholesterol accumulation in cells upon atherosclerosis.
Topics: Arteriosclerosis; Cholesterol; Coronary Disease; Electron Spin Resonance Spectroscopy; Erythrocytes; Fluorescence; Free Radicals; Humans; Lipid Peroxidation; Lipoproteins; Lipoproteins, LDL; Malondialdehyde; Monocytes; Oxidation-Reduction; Spin Labels | 1991 |
[The relation between coronary diseases and lipid peroxidation].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Coronary Disease; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Selenium; Superoxide Dismutase; Thromboxane B2 | 1991 |
Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury.
Topics: Animals; Cell Membrane; Chromatography, High Pressure Liquid; Coronary Disease; Creatine Kinase; Kinetics; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Phospholipids; Rabbits; Thiobarbiturates | 1991 |
[The sick sinus syndrome and lipid peroxidation: its possible role in the pathogenesis of the disease].
Topics: Adolescent; Adult; Antioxidants; Cholesterol; Coronary Disease; Humans; Hyperlipoproteinemias; Hypertension; Lipid Peroxidation; Lipoproteins; Malondialdehyde; Middle Aged; Myocarditis; Sick Sinus Syndrome | 1991 |
[Ceruloplasmin-transferrin antioxidant system in in experimental and clinical atherosclerosis].
Topics: Adult; Aged; Animals; Antioxidants; Arteriosclerosis; Ceruloplasmin; Cholesterol; Coronary Disease; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Rabbits; Transferrin | 1990 |
Lipid peroxidation during myocardial ischaemia induced by pacing.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Coronary Disease; Female; Humans; Lactates; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardium | 1990 |
Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease.
Topics: Aged; Chronic Disease; Coronary Disease; Free Radicals; Heart Failure; Humans; Male; Malondialdehyde; Middle Aged; Sulfhydryl Compounds | 1990 |
[Changes in antioxidative enzyme activity in patients with chronic heart failure].
Topics: Adult; Antioxidants; Cardiomyopathy, Dilated; Chronic Disease; Coronary Disease; Enzyme Activation; Erythrocytes; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase | 1990 |
[The protective effect of coenzyme Q10 on acute myocardial ischemia reperfusion in dogs].
Topics: Acetylglucosaminidase; Animals; Coenzymes; Coronary Disease; Dogs; Female; Male; Malondialdehyde; Mitochondria, Heart; Myocardial Reperfusion Injury; Myocardium; Ubiquinone | 1990 |
[Protective effects of Panax notoginseng saponins on experimental myocardial injury induced by ischemia and reperfusion in rat].
Topics: Animals; Calcium; Coronary Disease; Female; Ginsenosides; Male; Malondialdehyde; Myocardial Reperfusion Injury; Panax; Plants, Medicinal; Rats; Rats, Inbred Strains; Saponins; Superoxide Dismutase | 1990 |
Ischemia-reperfusion injury and histamine release in isolated guinea-pig heart: the role of free radicals.
Topics: Animals; Coronary Disease; Free Radicals; Guinea Pigs; Histamine Release; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Reperfusion Injury; Perfusion | 1989 |
[Superoxide dismutase activity and malonic dialdehyde level in blood platelets of patients with coronary disease].
Topics: Adult; Blood Platelets; Coronary Disease; Humans; Male; Malonates; Malondialdehyde; Middle Aged; Superoxide Dismutase | 1989 |
Oxygen-derived free radical damage in canine heart transplantation.
Topics: Animals; Cardiopulmonary Bypass; Coronary Disease; Creatine Kinase; Dogs; Free Radicals; Heart Function Tests; Heart Transplantation; Isoenzymes; Malondialdehyde; Myocardial Reperfusion; Myocardium; Oxygen; Postoperative Period | 1989 |
Individually controlled aspirin in the long-term treatment of patients with chronic arterial diseases.
Topics: Adenosine Diphosphate; Arteriosclerosis; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Female; Humans; Male; Malondialdehyde; Middle Aged; Platelet Aggregation | 1989 |
[Effect of verapamil on the functional status of thrombocytes in patients with ischemic heart disease].
Topics: Adult; Aged; Blood Platelets; Coronary Disease; Female; Humans; In Vitro Techniques; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Verapamil | 1989 |
[The role of lipid peroxidation in the pathogenesis of ischemic heart disease in miners in deep coal mines].
Topics: Angina Pectoris; Coal Mining; Coronary Disease; Dinoprost; Humans; Lipid Peroxidation; Malondialdehyde; Myocardial Infarction; Nucleotides, Cyclic; Occupational Diseases; Physical Exertion; Prostaglandins E; Ukraine | 1989 |
Reduction of lipid peroxidation in reperfused isolated rabbit hearts by diltiazem.
Topics: Animals; Coronary Disease; Diltiazem; Heart; Hypoxanthine; Hypoxanthines; In Vitro Techniques; Kinetics; Lipid Peroxidation; Male; Malonates; Malondialdehyde; Myocardial Reperfusion; Myocardium; Rabbits; Xanthine Oxidase | 1989 |
Evidence for increased lipid peroxidation in the non-ischaemic portion of the heart with coronary occlusion.
Topics: Animals; Coronary Disease; Fluorescence; Free Radicals; Lipid Peroxidation; Malondialdehyde; Myocardium; Swine | 1989 |
[Membrane lipid peroxidation in coronary insufficiency].
Topics: Animals; Coronary Disease; Creatine Kinase; Dogs; Free Radicals; Humans; Lipid Peroxides; Malonates; Malondialdehyde; Membrane Lipids; Oxygen; Time Factors | 1986 |
[Free radical toxicity in coronary insufficiency].
Topics: Aged; Cholesterol; Coronary Disease; Female; Free Radicals; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Triglycerides | 1986 |
Lipid peroxidation in normoxic and ischaemic-reperfused hearts of fish oil and lard fat fed pigs.
Topics: Animals; Coronary Disease; Diet; Dietary Fats; Female; Fish Oils; Lipofuscin; Male; Malondialdehyde; Membrane Lipids; Myocardium; Sarcolemma; Swine | 1988 |
Platelet arachidonic acid metabolism in patients with cardiovascular disorders.
Topics: Angina Pectoris; Arachidonic Acids; Blood Platelets; Coronary Disease; Humans; Malondialdehyde; Pentose Phosphate Pathway; Reference Values | 1988 |
Responsiveness of cardiac adenylate cyclase in the normal and ischemic myocardium. Role of oxygen free radicals.
Topics: Adenylyl Cyclases; Animals; Coronary Disease; Enzyme Activation; Free Radicals; In Vitro Techniques; Malondialdehyde; Myocardium; Oxygen; Rats; Sarcolemma; Swine | 1987 |
Protective effects of ginsenosides on anoxia/reoxygenation of cultured rat myocytes and on reperfusion injuries against lipid peroxidation.
Topics: Animals; Cells, Cultured; Coronary Disease; Ginsenosides; Hypoxia; L-Lactate Dehydrogenase; Lipid Peroxides; Malondialdehyde; Myocardium; Rats; Saponins; Superoxide Dismutase | 1987 |
Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers.
Topics: Animals; Blood Flow Velocity; Catalase; Coronary Disease; Creatine Kinase; Female; Free Radicals; Male; Malondialdehyde; Myocardial Revascularization; Myocardium; Oxygen; Oxygen Consumption; Perfusion; Potassium; Potassium Compounds; Premedication; Superoxide Dismutase; Swine | 1986 |
[Lipid peroxides and antioxidants in the blood of patients with arteriosclerotic circulatory disorders].
Topics: Arteriosclerosis; Cerebral Infarction; Coronary Disease; Glutathione Peroxidase; Humans; Ischemic Attack, Transient; Lipid Peroxides; Male; Malonates; Malondialdehyde; Middle Aged; Selenium; Vitamin E | 1985 |
[Changes in the optical properties of high-density lipoproteins in diabetics].
Topics: Arteriosclerosis; Coronary Disease; Diabetes Mellitus; Humans; Lipoproteins, HDL; Malondialdehyde; Micelles; Microscopy, Polarization; Spectrophotometry, Ultraviolet | 1985 |